When a family friend was diagnosed with leukemia, a young Dr. Nancy Collins knew that
she wanted to work in medicine to help people like him. This powerful experience led
her to pursuing a degree in biology and then her PhD in microbiology and immunology
in 1977 from the University of Rochester in New York. Since those days in the classroom,
Dr. Collins has embraced her passion, focusing her research on the translation of
cellular therapies from the research laboratory into clinical application, particularly
in hematopoietic stem cell transplantation. Her laboratory at Memorial Sloan-Kettering
Cancer Center developed a number of methods to improve the safety and efficacy of
hematopoietic cell transplantation and treatment of post-transplant complications,
working with bone marrow, peripheral blood stem cells, and cord blood cells. She was
the visionary first president of ISCT, playing a pivotal role in the genesis of ISCT
and the far-reaching global society it has become today. She was also a founding member
of the Foundation for the Accreditation of Cellular Therapy (FACT), which was jointly
instituted by ISCT and the American Society for Blood and Marrow Transplantation (ASBMT).
Over the years, Dr. Collins has inspired and mentored many up-and-coming cell and
gene professionals, teaching at the University of Toledo as well as acting as the
respected Senior Editor for ISCT's Telegraft newsletter.
To read this article in full you will need to make a payment
© 2019 Published by Elsevier B.V. on behalf of International Society for Cell and Gene Therapy.